Showing results (451-460 of 468) with videos related to
Sort By:
Pageof 47
Blood|September 1, 2011
The BCL11B tumor suppressor is mutated across the major molecular subtypes of T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Alex Kentsis, Takaomi Sanda, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2012
Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomesSteven E Lipshultz, Tracie L Miller, Rebecca E Scully, et al.Cancer Discovery|May 17, 2019
Single and Dual Targeting of Mutant EGFR with an Allosteric InhibitorCiric To, Jaebong Jang, Ting Chen, et al.Cancer Discovery|May 16, 2012
Molecular ontogeny of donor-derived follicular lymphomas occurring after hematopoietic cell transplantationOliver Weigert, Nadja Kopp, Andrew A Lane, et al.The Lancet. Oncology|May 18, 2013
Surrogate endpoints for overall survival in chemotherapy and radiotherapy trials in operable and locally advanced lung cancer: a re-analysis of meta-analyses of individual patients' dataAudrey Mauguen, Jean-Pierre Pignon, Sarah Burdett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 30, 2013
Postinduction dexamethasone and individualized dosing of Escherichia Coli L-asparaginase each improve outcome of children and adolescents with newly diagnosed acute lymphoblastic leukemia: results from a randomized study--Dana-Farber Cancer Institute ALL Consortium Protocol 00-01Lynda M Vrooman, Kristen E Stevenson, Jeffrey G Supko, et al.Pediatrics|November 21, 2012
Continuous Versus Bolus Infusion of Doxorubicin in Children With ALL: Long-term Cardiac OutcomesSteven E Lipshultz, Tracie L Miller, Stuart R Lipsitz, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 21, 2010
Absence of biallelic TCRgamma deletion predicts early treatment failure in pediatric T-cell acute lymphoblastic leukemiaAlejandro Gutierrez, Suzanne E Dahlberg, Donna S Neuberg, et al.Lung Cancer (Amsterdam, Netherlands)|June 16, 2019
Impact of MET inhibitors on survival among patients with non-small cell lung cancer harboring MET exon 14 mutations: a retrospective analysisMark M Awad, Giulia C Leonardi, Sasha Kravets, et al.Nature Medicine|June 12, 2012
Autocrine activation of the MET receptor tyrosine kinase in acute myeloid leukemiaAlex Kentsis, Casie Reed, Kim L Rice, et al.Pageof 47